Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alberto Serrano-Pozo, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Alberto Serrano-Pozo and Rudolph Tanzi.
Connection Strength

0.259
  1. Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 2013 May 22; 78(4):631-43.
    View in: PubMed
    Score: 0.141
  2. Author Correction: Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease. Nat Med. 2021 Feb; 27(2):356.
    View in: PubMed
    Score: 0.060
  3. Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease. Nat Med. 2020 08; 26(8):1256-1263.
    View in: PubMed
    Score: 0.058
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.